Guangdong New South Traditional Chinese Medicine Institute: Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect

GUANGZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating

Related Keywords

Guangzhou ,Guangdong ,China ,Kenya ,Nigeria ,Comoros ,Tanzania ,Zhong Nanshan ,Hunan ,Jilin ,Chinese ,Zhu Layi ,Prnewswire Artequick ,Kostenloser Wertpapierhandel ,Wang Xinhua ,Huo Jiangtao ,Guangdong New South Group ,Artemisinin Research Center ,National Health Commission Of China ,Guangzhou Institute Of Respiratory Health ,Guangzhou University Of Chinese Medicine ,Africa Guangdong Business Association ,Artepharm Co Ltd ,China National Medical Products Administration ,Guangzhou Medical University ,International Journal Of Antimicrobial Agents ,Guangdong New South Traditional Chinese Medicine Institute ,International Journal ,Antimicrobial Agents ,Professor Li Guoqiao Led ,Guangzhou University ,Chinese Medicine ,National Medical Products Administration ,National Health Commission ,Guangzhou Institute ,Respiratory Health ,Guangzhou Eighth People ,Guangdong Province ,Hongqi Hospital Affiliated ,Mudanjiang Medical University ,Guangdong New South ,Attachments Links ,Mouth ,Traditional ,Medicine ,Institute ,Sensational ,Artemisinin ,Iperaquine ,Treatment ,Covid ,Prospect ,